Branding & Naming Experience
Brand Institute excels as the global leader in brand name and identity development, spanning healthcare, consumer products, and pharmaceutical standards. With over 75% of drug name approvals globally and unparalleled success in consumer and business-to-business branding, it sets the industry benchmark. Additionally, it dominates USAN/INN naming, with significant majorities in drug name approvals worldwide.
1,456
Healthcare Clients
4,777
Total Healthcare Names
1,621
USAN/INN (Nonproprietary)
456
Consumer/B2B Clients
980
Total Consumer/B2B Names
94
Corporate Identities
General Search
Showing 1–16 of 19 results
Showing 1 - 16 out of 16
Page 1 out of 1
Name | Company | Category |
---|---|---|
Adcetris Seagen | Pfizer | |
Avastin | Genentech | |
Bimzelx | UCB | |
Brukinsa | BeiGene | |
Caplyta | Intra-Cellular Therapies | |
Coolsculpting Allergan | AbbVie | |
Entyvio | Takeda | |
Gemtesa | Sumitomo Pharma | |
Hemlibra | Genentech | |
Jeuveau | Evolus | |
Leqembi Biogen | Eisai | |
Livtencity | Takeda | |
Lucentis | Genentech | |
Lunesta | Waylis Therapeutics | |
Paxlovid | Pfizer | |
Rybelsus | Novo Nordisk |